Canada markets closed

Pharmala Biotech Holdings Inc. (MDMA.CN)

Canadian Sec - Canadian Sec Real Time Price. Currency in CAD
Add to watchlist
0.19000.0000 (0.00%)
At close: 03:59PM EDT
Currency in CAD

Valuation Measures4

Market Cap (intraday) 17.31M
Enterprise Value 17.27M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)12.81
Price/Book (mrq)12.89
Enterprise Value/Revenue 13.48
Enterprise Value/EBITDA -11.51

Trading Information

Stock Price History

Beta (5Y Monthly) N/A
52-Week Change 3-56.82%
S&P500 52-Week Change 326.43%
52 Week High 30.4850
52 Week Low 30.0850
50-Day Moving Average 30.1893
200-Day Moving Average 30.1769

Share Statistics

Avg Vol (3 month) 3455.9k
Avg Vol (10 day) 3255.6k
Shares Outstanding 591.12M
Implied Shares Outstanding 691.12M
Float 8N/A
% Held by Insiders 15.34%
% Held by Institutions 10.00%
Shares Short (Sept 15, 2023) 452.08k
Short Ratio (Sept 15, 2023) 40.14
Short % of Float (Sept 15, 2023) 4N/A
Short % of Shares Outstanding (Sept 15, 2023) 40.06%
Shares Short (prior month Aug 15, 2023) 421.32k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends N/A
Most Recent Quarter (mrq)N/A

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)N/A
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA N/A
Net Income Avi to Common (ttm)N/A
Diluted EPS (ttm)-0.0100
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)N/A
Total Cash Per Share (mrq)N/A
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)N/A
Book Value Per Share (mrq)N/A

Cash Flow Statement

Operating Cash Flow (ttm)N/A
Levered Free Cash Flow (ttm)N/A